Search
Quote for "exact phrases"
       
Sort order:    
Results 1 - 50 of 957

FDA Expands Flibanserin Approval to Postmenopausal Women With Hypoactive Sexual Desire Disorder
This Month in Psychpharmacology added 03/24/2026. CME credit is not available

Rethinking Mood Disorder Treatment with Immunometabolic Insights
This Month in Psychpharmacology added 03/19/2026. CME credit is not available

Exercise Demonstrates Moderate Effects for Depression and Anxiety Across the Lifespan
This Month in Psychpharmacology added 03/19/2026. CME credit is not available

Brain Awareness Week: March 16-22, 2026
This Month in Psychpharmacology added 03/16/2026. CME credit is not available

FDA Accepts New Drug Application (NDA) for Olanzapine Extended-Release Injectable Suspension
This Month in Psychpharmacology added 03/09/2026. CME credit is not available

Ketogenic Diet Shows Modest Short-Term Benefit in Treatment-Resistant Depression
This Month in Psychpharmacology added 03/05/2026. CME credit is not available

Long-Term Impact of Cognitive Training on Dementia Risk: 20-Year Outcomes From a Randomized Trial
This Month in Psychpharmacology added 03/03/2026. CME credit is not available

Preinjury Antidepressant Use Does Not Appear to Worsen Clinical Outcomes after TBI
This Month in Psychpharmacology added 02/27/2026. CME credit is not available

FDA Approves Milsaperidone for Schizophrenia and Acute Bipolar I Disorder
This Month in Psychpharmacology added 02/20/2026. CME credit is not available

Metformin Modestly Reduces BMI in Overweight Youth With Bipolar Disorders
This Month in Psychpharmacology added 02/13/2026. CME credit is not available

Serial Intravenous Ketamine Infusions Not Superior to Usual Inpatient Care for Depression
This Month in Psychpharmacology added 02/10/2026. CME credit is not available

Efficacy and Tolerability of Antipsychotics for Acute Schizophrenia
This Month in Psychpharmacology added 02/05/2026. CME credit is not available

FDA Grants Priority Review to Centanafadine for ADHD
This Month in Psychpharmacology added 01/28/2026. CME credit is not available

FDA Removes Suicidal Ideation Warning From GLP-1 Drugs
This Month in Psychpharmacology added 01/28/2026. CME credit is not available

Synthetic THC Shows Promise for Agitation Management in Alzheimer’s Patients
This Month in Psychpharmacology added 01/22/2026. CME credit is not available

NRX-101 Development Expanded to Include TMS for Depression
This Month in Psychpharmacology added 01/15/2026. CME credit is not available

FDA Approves Cariprazine for Pediatric Schizophrenia and Bipolar I Disorder
This Month in Psychpharmacology added 01/13/2026. CME credit is not available

Concurrent Metformin Use Linked to Better Adherence to Antipsychotics
This Month in Psychpharmacology added 01/06/2026. CME credit is not available

Preventing PTSD in Deploying Soldiers Using Attention Bias Modification
This Month in Psychpharmacology added 01/06/2026. CME credit is not available

Solutions to Common Issues in the Use of Long-Acting Injectable Antipsychotics
CNS Spectrums added 12/31/2025. CME credit is available

Understanding Long-Acting Injectable Antipsychotics in the Context of Treatment Planning: Crafting a Strategy
CNS Spectrums added 12/31/2025. CME credit is available

Long-Acting Injectable Antipsychotics for Patients With First-Episode and Early-Phase Schizophrenia: Still Not Considered Often Enough
CNS Spectrums added 12/28/2025. CME credit is available

Lies and LAIs: Why Accuracy of Information is the Key to Understanding the Benefits and the Resistance to Using Long-acting Formulation
CNS Spectrums added 12/27/2025. CME credit is available

This Year in Psychopharmacology - 2025
MPP: Articles added 12/23/2025. CME credit is available

Heart Rate, Cholesterol, and Weight Shifts Vary Widely Across Antidepressant Classes
This Month in Psychpharmacology added 12/12/2025. CME credit is not available

Cannabidiol Fails to Protect Against Cannabis-Induced Symptoms in Schizophrenia
This Month in Psychpharmacology added 12/12/2025. CME credit is not available

Novel Benzodiazepines Linked to More Severe Opioid Overdoses
This Month in Psychpharmacology added 12/12/2025. CME credit is not available

Patterns of Cannabis and Alcohol Use for Sleep Initiation in Young Adults
This Month in Psychpharmacology added 12/12/2025. CME credit is not available

Starting Benzodiazepines, Antipsychotics in Hospice with Dementia Linked to Increased Mortality
This Month in Psychpharmacology added 12/10/2025. CME credit is not available

Relapse Criteria in Schizophrenia
This Month in Psychpharmacology added 12/02/2025. CME credit is not available

Brief Cognitive Behavioral Therapy Shows Promise for Suicide Prevention in Military Populations
This Month in Psychpharmacology added 11/18/2025. CME credit is not available

Young Investigator Poster Awards
This Month in Psychpharmacology added 11/07/2025. CME credit is not available

FDA Approves Lumateperone as Adjunctive Treatment for Major Depressive Disorder
This Month in Psychpharmacology added 11/06/2025. CME credit is not available

Child and Adolescent Psychiatry Academy
This Month in Psychpharmacology added 11/05/2025. CME credit is not available

GLP-1 Receptor Agonists for the Treatment of Opioid Use Disorders
This Month in Psychpharmacology added 10/14/2025. CME credit is not available

Lurasidone Efficacious for Depression Across Psychiatric Diagnoses
This Month in Psychpharmacology added 10/10/2025. CME credit is not available

Advancing ADHD Awareness Through Evidence-Based Practice
This Month in Psychpharmacology added 10/10/2025. CME credit is not available

Chronic Insomnia Associated with Elevated Risk of Cognitive Decline
This Month in Psychpharmacology added 10/02/2025. CME credit is not available

APA Issues Guideline on Delirium Prevention and Treatment
This Month in Psychpharmacology added 10/02/2025. CME credit is not available

Lithium Deficiency and Alzheimer’s Disease: A Potential Modifiable Risk Factor
This Month in Psychpharmacology added 09/26/2025. CME credit is not available

SSRIs and SNRIs Lower Relapse in Clozapine Treated Schizophrenia
This Month in Psychpharmacology added 09/26/2025. CME credit is not available

Prolonged Exposure Therapy Effective Across Trauma Types and Populations
This Month in Psychpharmacology added 09/15/2025. CME credit is not available

Hearing Loss, Hearing Aid Use, and Neuropsychiatric Symptoms among Persons Living with Dementia
This Month in Psychpharmacology added 09/03/2025. CME credit is not available

Perinatal Mood Episodes In Fathers With Bipolar Disorder
This Month in Psychpharmacology added 09/03/2025. CME credit is not available

Behavioral Activation Program Reduces Suicide Ideation in Pregnancy and Postpartum
This Month in Psychpharmacology added 09/03/2025. CME credit is not available

Treatment for ADHD Reduces Multiple Risk Behaviors
This Month in Psychpharmacology added 08/26/2025. CME credit is not available

Clozapine Shows Greater Benefit in Schizoaffective Disorder
This Month in Psychpharmacology added 08/23/2025. CME credit is not available

FDA Approves Cyclobenzaprine For Fibromyalgia in Adults
This Month in Psychpharmacology added 08/15/2025. CME credit is not available

Increased Prescribing of ADHD Medication and Real-World Outcomes Over Time
This Month in Psychpharmacology added 08/11/2025. CME credit is not available

Oldest-Old Respond Better to ECT Than Younger Adults, Study Finds
This Month in Psychpharmacology added 08/11/2025. CME credit is not available

<< Back   1 2 3 4 5 6 7 8 9 10 ...   Next >>